HEPION PHARMACEUTICALS, INC. Deferred Income Tax Liabilities, Net
HEPION PHARMACEUTICALS, INC. (HEPA) had Deferred Income Tax Liabilities, Net of $0 as of 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2024-04-16
- 2023-12-31: Deferred Income Tax Liabilities, Net $0.00.
- 2023-09-30: Deferred Income Tax Liabilities, Net $409.02K.
- 2023-06-30: Deferred Income Tax Liabilities, Net $409.02K.
- 2023-03-31: Deferred Income Tax Liabilities, Net $409.02K.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-16 | |
| 2023-09-30 | $409.02K 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $409.02K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $409.02K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $409.02K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $409.02K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $409.02K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $409.02K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $409.02K 10-K · filed 2023-04-10 | |
| 2021-09-30 | $409.02K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $409.02K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $409.02K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $409.02K 10-K · filed 2022-04-08 | |
| 2020-09-30 | $409.02K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $49.18K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $18.75K 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $409.02K 10-K · filed 2021-03-31 | $18.75K 10-K · filed 2020-05-14 |
| 2019-09-30 | $360.70K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $360.70K 10-Q · filed 2019-08-14 | |
| 2018-12-31 | $360.70K 10-K · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |